3,6-dihydro-2-oxo-6H-1,3,4,-thiadiazine derivatives

US7534785B2 · kind B2 · utility

Assignee

• Merck Patentgesellschaft · DE

Inventors

• Oliver Schadt · Rodenbach, DE
• Dieter Dorsch · Ober-Ramstadt, DE
• Melanie Schultz · Darmstadt, DE
• Andree Blaukat · Heilbad Heiligenstadt, DE

Key dates

• Filing date: Oct 25, 2006
• Grant date: May 19, 2009
• Expiry date: Oct 25, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula I, in which R1, R2, Q and B have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.